ombitasvir/paritaprevir/ritonavir/dasabuvir

ombitasvir/paritaprevir/ritonavir/dasabuvir is a topic covered in the Davis's Drug Guide.

To view the entire topic, please or .

Emergency Central is a collection of disease, drug, and test information including 5-Minute Emergency Medicine Consult, Davis’s Drug, McGraw-Hill Medical’s Diagnosaurus®, Pocket Guide to Diagnostic Tests, and MEDLINE Journals created for emergency medicine professionals. Explore these free sample topics:

-- The first section of this topic is shown below --

General

Genetic Implications: Genetic Implications

Pronunciation:
om-bit-as-vir/par-i-ta-pre-vir/ri-toe-na-vir/da-sa-bue-vir

To hear audio pronunciation of this topic, purchase a subscription or log in.

Trade Name(s)

  • Holkira Pak Canadian Tradename
  • Viekira Pak

Ther. Class.
antivirals

Pharm. Class.
NS5 inhibitors
protease inhibitors
enzyme inhibitors
non-nucleoside NS5B palm

-- To view the remaining sections of this topic, please or --

General

Genetic Implications: Genetic Implications

Pronunciation:
om-bit-as-vir/par-i-ta-pre-vir/ri-toe-na-vir/da-sa-bue-vir

To hear audio pronunciation of this topic, purchase a subscription or log in.

Trade Name(s)

  • Holkira Pak Canadian Tradename
  • Viekira Pak

Ther. Class.
antivirals

Pharm. Class.
NS5 inhibitors
protease inhibitors
enzyme inhibitors
non-nucleoside NS5B palm

There's more to see -- the rest of this entry is available only to subscribers.